Table 2: Comparison of salivary TAC (Total Antioxidant Capacity) levels between patients with RAS in active lesion phase and control group.

Patients
(active lesion phase)
Control P value*
Salivary TAC concentrations
(Mmol / L)
0.26±0.16 0.24±0.13 0.641

* Unpaired t-test.

Back to Article